Table 4. Effect of Various Agents on the Cell Cycle Distribution of Human Stomach Cancer Cell Lines.
| Cell line/treatment | Sub G1 | G0/G1 | S | G2/M |
|---|---|---|---|---|
| HGC-27 | ||||
| Control | 0.17 ± 0.05 | 65.49 ± 2.24 | 10.50 ± 4.31 | 18.87 ± 6.49 |
| Afatinib | 1.71 ± 1.84 | 45.86 ± 12.56 | 14.32 ± 2.84 | 35.53 ± 16.45 |
| Dinaciclib | 34.36 ± 9.44 | 25.12 ± 2.98 | 30.05 ± 10.77 | 5.33 ± 0.15 |
| Dasatinib | 0.37 ± 0.20 | 58.19 ± 8.75 | 10.13 ± 0.88 | 29.02 ± 8.82 |
| Stattic | 0.70 ± 0.70 | 46.01 ± 0.98 | 12.77 ± 0.78 | 36.58 ± 1.99 |
| Paclitaxel | 31.20 ± 15.22 | 24.62 ± 1.21 | 16.47 ± 3.59 | 23.18 ± 10.97 |
| AGS | ||||
| Control | 3.77 ± 0.28 | 49.68 ± 1.33 | 16.90 ± 0.42 | 23.89 ± 0.25 |
| Afatinib | 18.65 ± 6.12 | 51.16 ± 5.66 | 10.22 ± 2.73 | 16.97 ± 3.42 |
| Dinaciclib | 36.70 ± 1.02 | 28.18 ± 0.50 | 16.21 ± 0.01 | 16.47 ± 0.93 |
| Dasatinib | 33.98 ± 6.68 | 30.27 ± 3.59 | 11.87 ± 1.59 | 14.79 ± 2.02 |
| Stattic | 31.62 ± 1.41 | 35.20 ± 4.85 | 15.27 ± 2.27 | 15.09 ± 0.68 |
| Paclitaxel | 53.82 ± 3.24 | 20.95 ± 9.72 | 12.94 ± 4.62 | 17.49 ± 0.45 |
| FU97 | ||||
| Control | 1.79 ± 0.67 | 80.85 ± 4.69 | 6.64 ± 2.09 | 9.38 ± 2.90 |
| Afatinib | 3.31 ± 2.43 | 82.15 ± 4.90 | 7.30 ± 3.27 | 5.87 ± 3.68 |
| Dinaciclib | 53.01 ± 2.88 | 35.57 ± 3.56 | 6.03 ± 0.11 | 3.27 ± 0.14 |
| Dasatinib | 6.29 ± 4.44 | 84.68 ± 3.34 | 2.07 ± 0.51 | 5.03 ± 0.06 |
| Stattic | 5.62 ± 4.13 | 81.35 ± 1.13 | 4.79 ± 2.78 | 6.43 ± 1.50 |
| Paclitaxel | 55.28 ± 0.69 | 17.79 ± 0.99 | 4.38 ± 0.81 | 21.13 ± 1.25 |
| MKN1 | ||||
| Control | 1.51 ± 0.68 | 72.33 ± 6.87 | 8.41 ± 1.22 | 14.65 ± 3.56 |
| Afatinib | 1.82 ± 0.49 | 78.58 ± 1.47 | 7.76 ± 1.53 | 8.63 ± 0.52 |
| Dinaciclib | 18.12 ±2.73 | 5.19 ± 2.57 | 71.36 ± 4.97 | 4.11 ± 0.06 |
| Dasatinib | 2.33 ± 0.37 | 75.78 ± 0.75 | 8.01 ± 1.28 | 10.23 ± 1.43 |
| Stattic | 2.29 ± 0.04 | 83.23 ± 1.26 | 6.03 ± 0.24 | 6.40 ± 0.18 |
| Paclitaxel | 10.32 ± 0.34 | 52.10 ± 2.15 | 13.67 ± 0.20 | 21.73 ± 1.59 |
| MKN74 | ||||
| Control | 4.99 ± 0.69 | 53.79 ± 2.41 | 13.88 ± 3.04 | 25.20 ± 0.54 |
| Afatinib | 8.54 ± 1.78 | 63.30 ± 1.29 | 11.16 ± 1.75 | 15.88 ± 0.86 |
| Dinaciclib | 26.75 ± 4.00 | 47.79 ± 3.20 | 7.85 ± 2.74 | 15.11 ± 2.60 |
| Dasatinib | 4.52 ± 0.04 | 64.39 ± 4.00 | 13.56 ± 0.47 | 15.43 ± 3.83 |
| Stattic | 16.56 ± 1.61 | 52.37 ± 1.30 | 11.94 ± 0.53 | 16.83 ± 2.67 |
| Paclitaxel | 50.35 ± 1.63 | 13.35 ± 0.05 | 13.31 ± 1.87 | 18.07 ± 1.24 |
| NCI-N87 | ||||
| Control | 2.09 ± 0.16 | 56.23 ± 2.75 | 15.71 ± 3.40 | 22.41 ± 1.63 |
| Afatinib | 8.15 ± 1.97 | 56.54 ± 3.95 | 10.66 ± 3.81 | 18.63 ± 0.11 |
| Dinaciclib | 52.70 ± 4.74 | 37.20 ± 2.65 | 2.72 ± 0.13 | 4.35 ± 0.70 |
| Dasatinib | 8.10 ± 3.78 | 62.53 ± 4.48 | 7.28 ± 0.86 | 14.91 ± 1.27 |
| Stattic | 11.95 ± 5.08 | 55.87 ± 7.33 | 10.33 ± 5.08 | 17.04 ± 8.41 |
| Paclitaxel | 39.35 ± 7.01 | 21.15 ± 7.60 | 13.28 ± 3.00 | 17.64 ± 9.47 |
Each value is expressed as mean ± SD. SD: standard deviation.